|
|
|
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
Industry-Leading Risk-Based Quality Management Event Focuses on the Maturity of RBQM, its Increasing Value, and the Vision for the Future |
 |
|
CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor
King of Prussia, PA – August 30, 2022: Industry-leading risk-based study execution and data quality oversight software provider, CluePoints, is proud to announce its role as the premier event sponsor of RBQM Live 2022. The two-day virtual event is a must-attend for everyone currently working with or planning to adopt risk-based quality management (RBQM) in clinical trials. The event provides a unique opportunity to discuss the current landscape, look to the future, and share practical experiences. There is something for everyone to ensure RBQM success, no matter the size of the organization or the experience of the delegate.
Day 1, on September 8 th, will focus on RBQM Maturity — Insights into Current Trends and Increasing Value. The keynote address, “How the Evolving RBQM Landscape Will Reinforce the Way We Improve Efficiencies & Add Value,” will be given by Professor Ken Getz of the Tufts Center for the Study of Drug Development.
Other highlights include panel discussions on interpreting quality tolerance limits (QTLs), moderated by CluePoints’ Chief Scientific Officer Steve Young, and accounting for the risks of decentralized clinical trials as sources of data increase. In addition, there will be a briefing on the ICH E6 (R3) and E8 (R1) guidance updates, led by Jonathan Rowe, Principal, Head of R&D Quality, Operations and Risk Management at ZS Associates, and a session around RBQM Diversification: tSDV, tSDR, Dynamic Site Monitoring Strategies.
The theme for the second day, September 9 th, is Advancing RBQM — Where Are We Heading in the Future? The keynote for day two will feature a fireside discussion with Demetris Zambas, Global Clinical Operations Leader, Pfizer, and Mayank Anand, VP and Global Head Data Strategy, Management and Centralized Monitoring, GSK debating “How AI and Machine Learning play an essential part in the future of RBQM.”
In addition, there will be discussions around RBQM best practices defined by leading working groups. Rounding out the event will be two insightful panel discussions. One will focus on leveraging RBQM in new ways you never envisioned and then the event will close with a discussion around what transformative outcomes from the last two years are here to stay.
Patrick Hughes, CluePoints Co-Founder, enthuses: “Risk-Based Quality Management adoption continues to grow rapidly and there are many more companies now on the journey than ever before. Further, as market factors drive the rapid growth of decentralized clinical trials, there is even greater scope for organizations to embrace RBQM to ensure effective oversight of the various disparate data sources. RBQM Live 2022, sponsored by CluePoints, will host some of the industry’s leading speakers to discuss the impact and value of RBQM today and what we can all look forward to in the near future. RBQM is here to stay and these sessions will reinforce what you can and should do to ensure success for you and your team.
The definitive guide to RBQM for beginners and experts alike occurs on September 8 and 9, 2022. Specialists from across the sector will gather to consider the current climate for adopting RBQM by CROs and sponsors, as well as looking ahead to implications for the future.”
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Gerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform Gerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform
Two leading companies introduce EZ-fill Smart™, the new Ready-To-Fill
solution platform for the global vial market. Customers benefit from
reduced Total Cost of Ownership, lower process complexity and
accelerated speed to market. The new platform ensures higher product
quality and enhanced process sustainability by introducing an
alternative sterilization method.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial-Specific Travel Programs as a Patient Retention Tool
For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >> |
|
|
.jpg){kind=small}
